Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Turkish

Breadcrumb

  1. Home
  2. Microbiota 21 - June 2024
  3. Can you ”hack” into your gut to obtain the slimming effects of a drug for diabetes?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Microbiota 21 - June 2024
  3. Can you ”hack” into your gut to obtain the slimming effects of a drug for diabetes?

Can you ”hack” into your gut to obtain the slimming effects of a drug for diabetes?

By Dr. Julien Scanzi
Department of Gastroenterology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

About this article

Author

 Julien Scanzi Dr Julien Scanzi
Created 20 June 2024
Updated 29 August 2024

Dr. DeDecker, an internal medicine specialist, has posted a short video on her TikTok channel explaining how people can benefit from the slimming effect of a drug without actually taking it. The drug in question is a GLP-1 analogue in the form of an injectable pen. It is indicated for the treatment of diabetes but is widely misused for its slimming effect, particularly in the United States, with female influencers even promoting it on social networks. The doctor explains that it is possible to achieve the slimming effect of this drug, which can help people lose up to 20% of their bodyweight, using two ”natural” methods, thanks to the gut microbiome, by taking a specific probiotic and by eating a fibre-rich diet.

Could you talk about the claims made on the video from a clinical perspective?

This drug increases GLP-1, which is a hormone primarily produced by the endocrine cells (also called enteroendocrine cells) in the gut. It boosts the secretion of insulin (incretin effect), slows down gastric emptying and stimulates the sensation of being full, making you feel less hungry.

What about fibre and taking a probiotic?

It is well known that dietary fibre, especially soluble fibre, can slow down gastric emptying, making you feel full and help control your appetite. Fibre can also help stabilise blood sugar levels by slowing down the absorption of carbohydrates, which can be beneficial in diabetic patients. What’s more, fibre-rich food often has a lower energy density, which can help reduce the overall calorie intake and potentially help patients to lose weight when eaten as part of a balanced diet. In terms of the gut microbiota, I agree with Dr. DeDecker about the fact that most fibre has a prebiotic effect and will nourish certain gut bacteria, which are then able to produce short-chain fatty acids (SCFAs) through fermentation, and these SCFAs can increase GLP-1 levels.

I would, however, qualify the statements about the bacterium she mentions, Akkermansia muciniphila, which she credits with tremendous benefits in terms of regulating energy metabolism and insulin sensitivity, as some studies have suggested it plays an indirect role in regulating the secretion of intestinal peptides such as GLP-1. However, this is preclinical data, and the link could be a fairly indirect one. Thus, there is no evidence to claim that supplementation with this bacterium could increase GLP-1 secretion and lead to weight loss.

Why do you think that this video has attracted so much attention? 

In my opinion, it was very easy for this video to create a buzz because it deals with weight loss, and in the West with our high rates of overweight and obese people (50-60% of the population), there are many who dream of being able to lose weight without changing their lifestyle, particularly their diet. So if you suggest that a natural method exists to lose 20% of your bodyweight without taking a drug, you can easily see why it appealed to so many people.

Would you give this information to your patients?

What could be the risks and/or pitfalls? That’s my personal opinion and I think that Dr. DeDecker’s comments are somewhat misleading, because neither taking any kind of probiotic nor increasing dietary fibre has shown any benefit in terms of weight loss, let alone a 20% one. However, despite these misgivings, I do think what she has to say is interesting as it could have the positive effect of reducing the misuse of anti-diabetic medication, as well as raising public awareness of the impact of the gut microbiota on our health. And, more importantly, she is encouraging people to eat more fibre. The current consumption of fibre in Western countries (less than 20 g/day) is well below the World Health Organisation’s recommendations (25-30 g/day), and only 5% of Americans eat enough fibre.

Image
Tags
Microbiome Flora
    Focus
    Microbiota 21 - June 2024
    • Overview
      • Diarrhea and the role of microbiota
    • Commented article
      • Faecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
      • Longitudinal analysis of the gut microbiome in adolescent patients with anorexia nervosa: microbiome-related factors associated with clinical outcome
    • Focus on young researchers
      • Gut microbiota from post-Covid-19 patients induces lung inflammation and brain dysfunction in mice [1]
    • Congress review
      • APDW summary
    • Press review
      • Gut Microbiota #21
      • Vaginal Microbiota #21
    • Expert opinion
      • Can you ”hack” into your gut to obtain the slimming effects of a drug for diabetes?
    Created 20 June 2024
    Updated 29 August 2024

    About this article

    To know more about this topic.

    Content type

    Expert opinion

    Author

     Julien Scanzi Dr Julien Scanzi
    Vaginal Microbiota #21
    Focus

    Microbiota 21 - June 2024

    Overview

    Diarrhea and the role of microbiota

    Commented article

    Faecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial Longitudinal analysis of the gut microbiome in adolescent patients with anorexia nervosa: microbiome-related factors associated with clinical outcome

    Focus on young researchers

    Gut microbiota from post-Covid-19 patients induces lung inflammation and brain dysfunction in mice [1]

    Congress review

    APDW summary

    Press review

    Gut Microbiota #21 Vaginal Microbiota #21

    Expert opinion

    Can you ”hack” into your gut to obtain the slimming effects of a drug for diabetes?
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Turkish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo